| 1 |
Verheyden S, Demanet C. NK cell receptors and their ligands in leukemia[J]. Leukemia, 2008, 22(2):249-257.
|
| 2 |
Trinchieri G. Biology of natural killer cells[J]. Adv Immunol, 1989, 47:187-376.
|
| 3 |
Ljunggren HG, Karre K.In search of the"missing self": MHC molecules and NK cell recognition[J]. Immunol Today, 1990, 11(7):237-244.
|
| 4 |
Uhrberg M, Valiante NM, Young NT, et al.The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns[J].J Immunol, 2001, 166(6):3923-3932.
|
| 5 |
Yawata M, Yawata N, Abi-Rached L, et al.Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family[J]. Crit Rev Immunol, 2002, 22(5-6):463-482.
|
| 6 |
Parham P. Immunogenetics of killer cell immunoglobulin-like receptors[J]. Mol Immunol, 2005, 42(4):459-462.
|
| 7 |
Wilson MJ, Torkar M, Haude A, et al. Plasticity in the organization and sequences of human KIR/ILT gene families[J]. Proc Natl Acad Sci USA, 2000, 97(9):4778-4783.
|
| 8 |
Uhrberg M, Valiante NM, Shum BP, et al. Human diversity in killer cell inhibitory receptor genes[J]. Immunity, 1997, 7(6):753-763.
|
| 9 |
Witt CS, Dewing C, Sayer DC, et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination[J].Transplantation, 1999, 68(11):1784-1789.
|
| 10 |
Parham P, Norman PJ, Abi-Rached L, et al.Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules[J]. Philos Trans R Soc Lond B Biol Sci, 2012, 367(1590):800-811.
|
| 11 |
Bryceson YT, Long EO. Line of attack: NK cell specificity and integration of signals[J]. Curr Opin Immunol, 2008, 20(3):344-352.
|
| 12 |
Lanier LL. Natural killer cell receptor signaling[J]. Curr Opin Immunol, 2003, 15(3):308-314.
|
| 13 |
Lanier LL. NK cell recognition[J]. Annu Rev Immunol, 2005, 23:225-274.
|
| 14 |
Maxwell LD, Williams F, Gilmore P, et al. Investigation of killer cell immunoglobulin-like receptor gene diversity: Ⅱ. KIR2DS4[J]. Hum Immunol, 2004, 65(6):613-621.
|
| 15 |
Middleton D, Gonzalez A, Gilmore PM.Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations[J]. Hum Immunol, 2007, 68(2):128-134.
|
| 16 |
Hsu KC, Liu XR, Selvakumar A, et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets[J]. J Immunol, 2002, 169(9):5118-5129.
|
| 17 |
Yawata M, Yawata N, Draghi M, et al. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function[J]. J Exp Med, 2006, 203(3):633-645.
|
| 18 |
Whang DH, Park H, Yoon JA, et al. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families[J]. Hum Immunol, 2005, 66(2):146-154.
|
| 19 |
Bao X, Hou L, Sun A, et al. Distribution of killer cell immunoglobulin-like receptor genes and 2DS4 alleles in the Chinese Han population[J]. Hum Immunol, 2010, 71(3):289-292.
|
| 20 |
Gomez-Lozano N, Vilches C.Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update[J]. Tissue Antigens, 2002, 59(3):184-193.
|
| 21 |
Luszczek W, Majorczyk E, Nowak I, et al. Inhibitory and activatory KIR gene frequencies in the Polish population[J]. Int J Immunogenet, 2006, 33(3):167-170.
|
| 22 |
Lanier LL, Corliss BC, Wu J, et al. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells[J]. Nature, 1998, 391(6668):703-707.
|
| 23 |
Kusnierczyk P. Are killer cell immunoglobulin-like receptor genes important for the prediction of kidney graft rejection?[J].Arch Immunol Ther Exp (Warsz), 2013, 61(4):321-325.
|
| 24 |
Katz G, Markel G, Mizrahi S, et al. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4[J]. J Immunol, 2001, 166(12):7260-7267.
|
| 25 |
Graef T, Moesta AK, Norman PJ, et al. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C[J]. J Exp Med, 2009, 206(11):2557-2572.
|
| 26 |
Merino A, Malhotra R, Morton M, et al. Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples[J]. J Infect Dis, 2011, 203(4):487-495.
|
| 27 |
Katz G, Gazit R, Arnon TI, et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4[J]. J Immunol, 2004, 173(3):1819-1825.
|
| 28 |
Hong HA, Paximadis M, Gray GE, et al. KIR2DS4 allelic variants: differential effects on in utero and intrapartum HIV-1 mother-to-child transmission[J].Clin Immunol, 2013, 149(3):498-508.
|
| 29 |
Zhuang YL, Zhu CF, Zhang Y, et al. Association of KIR2DS4 and its variant KIR1D with syphilis in a Chinese Han population[J]. Int J Immunogenet, 2012, 39(2):114-118.
|
| 30 |
Taniguchi M, Kawabata M. KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection[J]. Immunogenetics, 2009, 61(11-12):717-730.
|
| 31 |
Shilling HG, Guethlein LA, Cheng NW, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype[J]. J Immunol, 2002, 168(5):2307-2315.
|
| 32 |
Norman PJ, Abi-Rached L, Gendzekhadze K, et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans[J]. Nat Genet, 2007, 39(9):1092-1099.
|
| 33 |
Paladino N, Flores AC, Marcos CY, et al. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus[J]. Tissue Antigens, 2007, 69(Suppl 1):109-111.
|
| 34 |
Pan N, Jiang W, Sun H, et al. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study[J]. PLoS One, 2011, 6(10):e25682.
|
| 35 |
De Re V, Caggiari L, De Zorzi M, et al. Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy[J]. PLoS One, 2014, 9(1):e84940.
|
| 36 |
Giebel S, Nowak I, Wojnar J, et al. Association of KIR2DS4 and its variant KIR1D with leukemia[J]. Leukemia, 2008, 22(11):2129-2130; discussion 2130-2131.
|
| 37 |
Zhang Y, Wang B, Ye S, et al. Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease[J]. Leuk Res, 2010, 34(1):55-58.
|
| 38 |
Kusnierczyk P, Giebel S, Nowak I. Association of KIR2DS4 gene with susceptibility to leukemia: Chinese-Polish discrepancy[J]. Leuk Res, 2011, 35(11):1540.
|
| 39 |
Almalte Z, Samarani S, Iannello A, et al. Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia[J]. Blood, 2011, 118(5):1323-1328.
|
| 40 |
Babor F, Manser A, Schonberg K, et al. Lack of association between KIR genes and acute lymphoblastic leukemia in children[J]. Blood, 2012, 120(13):2770-2772.
|
| 41 |
Nowak I, Magott-Procelewska M, Kowal A, et al. Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation[J]. PLoS One, 2012, 7(9):e44718.
|
| 42 |
Gomez-Lozano N, Estefania E, Williams F, et al.The silent KIR3DP1 gene(CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated[J]. Eur J Immunol, 2005, 35(1):16-24.
|
| 43 |
Karre K. Immunology. A perfect mismatch[J]. Science, 2002, 295(5562):2029-2031.
|
| 44 |
Feuchtinger T, Pfeiffer M, Pfaffle A, et al. Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class Ⅰ expression on blasts and the differential KIR phenotype of NK clones[J]. Bone Marrow Transplant, 2009, 43(11):875-881.
|
| 45 |
GM, Franck AE, Li X, et al. Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection[J]. Biol Blood Marrow Transplant, 2011, 17(11):1662-1672.
|
| 46 |
Gagne K, Brizard G, Gueglio B, et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome[J]. Hum Immunol, 2002, 63(4):271-280.
|
| 47 |
Bao XJ, Hou LH, Sun AN, et al. The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT[J]. Bone Marrow Transplant, 2010, 45(9):1435-1441.
|
| 48 |
Chen C, Busson M, Rocha V, et al. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders[J]. Bone Marrow Transplant, 2006, 38(6):437-444.
|
| 49 |
Cooley S, McCullar V, Wangen R, et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation[J]. Blood, 2005, 106(13):4370-4376.
|
| 50 |
Legaz I, Lopez-Alvarez MR, Campillo JA, et al. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury[J]. Transplantation, 2013, 95(8):1037-1044.
|
| 51 |
Zhou J, Tang X, Ding Y, et al. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis[J]. Pediatr Allergy Immunol, 2013, 24(7):691-696.
|
| 52 |
Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success[J]. J Exp Med, 2004, 200(8):957-965.
|